The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care.

Ethiopia Xpert MTB/RIF bacteriologically confirmed children diagnosis point of care simple one-step stool method sputum stool tuberculosis

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
19 07 2021
Historique:
pubmed: 3 6 2021
medline: 29 7 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

Young children cannot easily produce sputum for diagnosis of pulmonary tuberculosis (TB). Alternatively, Mycobacterium tuberculosis complex bacilli can be detected in stool by using the Xpert MTB/RIF (Ultra) assay (Xpert). Published stool processing methods contain somewhat complex procedures and require additional supplies. The aim of this study was to develop a simple one-step (SOS) stool processing method based on gravity sedimentation only, similar to Xpert testing of sputum samples, for the detection of M. tuberculosis in stool samples. We first assessed whether the SOS stool method could provide valid Xpert results without the need for bead-beating, dilution, and filtration steps. We concluded that this was the case, and we then validated the SOS stool method by testing spiked stool samples. By using the SOS stool method, 27 of the 29 spiked samples gave valid Xpert results, and M. tuberculosis was recovered from all 27 samples. The proof of principle of the SOS stool method was demonstrated in routine settings in Addis Ababa, Ethiopia. Nine of 123 children with presumptive TB had M. tuberculosis-positive results for nasogastric aspiration (NGA) samples, and 7 (77.8%) of those children also had M. tuberculosis-positive Xpert results for stool samples. Additionally, M. tuberculosis was detected in the stool samples but not the NGA samples from 2 children. The SOS stool processing method makes use of the standard Xpert assay kit, without the need for additional supplies or equipment. The method can potentially be rolled out to any Xpert site, bringing a bacteriologically confirmed diagnosis of TB in children closer to the point of care.

Identifiants

pubmed: 34076469
doi: 10.1128/JCM.00406-21
pmc: PMC8373220
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0040621

Références

PLoS One. 2019 Sep 4;14(9):e0221145
pubmed: 31483793
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29997199
J Clin Microbiol. 2019 May 24;57(6):
pubmed: 30944200
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84
pubmed: 21836139
JGH Open. 2019 Aug 20;4(2):215-220
pubmed: 32280767
Clin Infect Dis. 2013 Aug;57(3):e18-21
pubmed: 23580738
Tuberculosis (Edinb). 2020 Dec;125:102002
pubmed: 33049437
Eur Respir J. 2019 Mar 14;53(3):
pubmed: 30578382
Lancet Infect Dis. 2008 Aug;8(8):498-510
pubmed: 18652996
Tuberculosis (Edinb). 2019 Dec;119:101878
pubmed: 31670064
J Clin Microbiol. 2010 Jan;48(1):229-37
pubmed: 19864480
Sci Rep. 2015 Apr 01;5:9551
pubmed: 25828383
J Vis Exp. 2012 Apr 09;(62):e3547
pubmed: 22508485
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32493780
Clin Infect Dis. 2010 May 15;50 Suppl 3:S184-94
pubmed: 20397947
Public Health Action. 2018 Mar 21;8(1):2-6
pubmed: 29581936
Open Forum Infect Dis. 2015 May 22;2(2):ofv074
pubmed: 26125035
Clin Infect Dis. 2016 May 1;62(9):1161-1168
pubmed: 26908804
PLoS One. 2016 Mar 23;11(3):e0151980
pubmed: 27007974
J Appl Microbiol. 2012 Nov;113(5):1014-26
pubmed: 22747964

Auteurs

Petra de Haas (P)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Bazezew Yenew (B)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Endale Mengesha (E)

KNCV Tuberculosis Foundation Ethiopia Office, Addis Ababa, Ethiopia.

Andrii Slyzkyi (A)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Zewdu Gashu (Z)

KNCV Tuberculosis Foundation Ethiopia Office, Addis Ababa, Ethiopia.

Manon Lounnas (M)

UMR MIVEGEC IRD-CNRS-University of Montpellier, IRD, Montpellier, France.

Ephrem Tesfaye (E)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Ahmed Bedru (A)

KNCV Tuberculosis Foundation Ethiopia Office, Addis Ababa, Ethiopia.

Edine Tiemersma (E)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Kristin Kremer (K)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Misikir Amare (M)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Getu Diriba (G)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Betselot Zerihun (B)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Tilaye Gudina (T)

National Tuberculosis and Leprosy Control Program, Addis Ababa, Ethiopia.

Ben Tegegn (B)

Addis Ababa Regional Health Bureau, Addis Ababa, Ethiopia.

Maryline Bonnet (M)

IRD UMI 233 Trans-VIHMI-UM-INSERM U1175, Montpellier, France.

Challa Negeri (C)

KNCV Tuberculosis Foundation Ethiopia Office, Addis Ababa, Ethiopia.

Eveline Klinkenberg (E)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.
Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH